Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Aug 2, 2017, after the close
10-Q filed Aug 2, 2017, 33 days after period end · 0001299130-17-000060
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $20.07M | $20.75M | $24.94M | $11.43M |
| Net Income | -$25.54M | -$18.50M | -$11.94M | -$19.14M |
| EPS Diluted | -$0.26 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.21 |
| -$0.16 |
| -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
